NCT00524823Unknown不适用
Early Detection of Prostate Cancer by FACS
Ziv Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2007年8月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
Early detection of prostrate cancer and development of metastases. The research will attempt to match the SCM test (structuredness of the cytoplasmic matrix) in lymphocytes as an early cancer detection test using Florescent Activated Cell Sorting (FACS) as a replacement for the CellScan instrument. The test is based on measurement of cellular changes in response to the specific prostate antigen, PSA.
研究设计
- 研究类型
- Observational
- 观察模型
- Defined Population
- 时间视角
- Prospective
入排标准
- 年龄范围
- 60 Years 至 90 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Experimental group : Males between the ages of 60-90 years, with medical diagnosis of prostate cancer according to both clinical and hematological examinations, before receiving any medical treatment.
- •Control Group 1: Males between the ages of 60-90 years, with diagnosed benign prostate hyperplasia -BPH.
- •Control Group 2: Males between the ages of 60-90 years, medically diagnosed as healthy.
- •Control Group 3: Males between the ages of 60-90 years, medically diagnosed with another form of cancer, not prostate.
排除标准
- •Experimental group: Other known cancer or systemic infection. Control Group 1: Other known cancer or systemic infection. Control Group 2:Past hematological disorders nor cancer growth history. other known systemic infection, nor urinary tract infection. Patients hospitalized for orthopedic injuries of any type who are otherwise free of urinary tract infections.
- •Control Group 3:Other known systemic infection, nor urinary tract infection.
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Early and Accurate Detection of Prostate Cancer in General PracticeProstate NeoplasmProstate AdenocarcinomaProstate CancerNCT03431753Aarhus University Hospital3,000
撤回
不适用
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMCProstate AdenocarcinomaProstate Cancer MetastaticProstate CancerNCT03494803HKGepitherapeutics
已完成
2 期
Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized DiseaseCancerNCT03081884Emory University61
Unknown
不适用
Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mLProstate CancerNCT04317625The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School232
已完成
不适用
Biparametric MRI for Detection of Significant Prostate CancerProstate CancerNCT02584179Herlev Hospital1,063